期刊文献+

土萆四妙汤配合非布司他治疗痛风和(或)高尿酸血症疗效性的系统评价 被引量:5

System Evaluation Effect on Tubisimiaotang Combine With Febuxostat in Treatment of Gout and(or) Hyperuricemia
下载PDF
导出
摘要 目的 对土萆四妙汤配合非布司他治疗痛风和(或)高尿酸血症疗效进行系统评估。方法 选取我院2014年1月-2015年1月收治的有痛风症状的高尿酸血症患者120例进行分组治疗,其中对照组患者给予别嘌醇进行治疗,非布司他组患者给予单纯的非布司他进行治疗,联合组在非布司他治疗的基础上给予中药汤剂加土萆四妙汤联合应用进行治疗,检测患者的疗效性指标。结果 在临床疗效指标的比较中,联合组的临床疗效高于非布司他单一用药组及对照组,P〈0.05,差异具有统计学意义。结论 中药联合非布司他对痛风及高尿酸血症具有更好的临床应用价值。 Objective System evaluation effect on tubisimiaotang combine with febuxostat in treatment of gout and (or) hyperuricemia. Methods Selected 120 cases of gout symptoms with hyperuricemia cases from January 2014 to January 2015 in our hospital, the control group were treated with allopurinol treatment, the febuxostat group was given a simple febuxostat treatment, decoction combined group was given on the basis of his treatment of febuxostat added the tubisimiaotang treatment, detection the effect index of patients. Results In comparative clinical indicators of the combination group efifcacy was higher than the febuxostat monotherapy group and the control group, P〈0.05, had difference statistically significance. Conclusions Chinese medicine combine with febuxostat has better clinical value of gout and hyperuricemia.
出处 《中国继续医学教育》 2015年第16期188-190,共3页 China Continuing Medical Education
关键词 土萆四妙汤 非布司他 痛风 高尿酸血症 系统评估 Tubisimiaotang, Febuxostat, Gout, Hyperuricemia, System evaluatio
  • 相关文献

参考文献12

  • 1Tojimbara T, Nakajima I, Yashima J, et al. Efficacy aud safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in kidney transplant recipients[J]. Transplantation proceedings, 2014, 46 ( 2 ) : 511-513. 被引量:1
  • 2Maekawa M, Tornida H, Aoki T, et al. Successt\d treatment of refractory gout using combined therapy consisting of febuxostat and allopurinol in a patient with chronic renal tMlure[J]. Internal medicine, 2014, 53 ( 6 ) : 609-612. 被引量:1
  • 3Kang Y, Kim M J, Jang H N, et al. Rhabdomyolysis associated with initiation of febuxostat therapy for hyperuricaemia in a patient with chronic kidney disease[J]. Journal of clinical pharmacy and therapeutics, 2014, 39 ( 3 ) : 328-330. 被引量:1
  • 4Sofue T, hmi M, Hara T, et al. Efficacy and sat)ty of febuxostat inthe treatment of hyperuricemia in stable kidney transplant recipients[J]. Drug design, development and therapy, 2014, 17 ( 8 ) : 245-253. 被引量:1
  • 5Frazziano G, A1 Ghouleh I, Baust J, et al. Nox-derived ROS are acutely activated in pressure overload pulmonary hypertension: indications for a seminal role for mitochondrial Nox4[J]. American journal of physiology Heart and circulatory physiology, 2014, 306 (2) : H197-205. 被引量:1
  • 6吴东海.痛风和高尿酸血症治疗中几个有争议的问题[J].中华风湿病学杂志,2012,16(6):361-363. 被引量:10
  • 7Hiramitsu S, Ishiguro Y, Matsuyama H, et al. Febuxostat (Feburic tablet) in the management of hyperuricemia in a general practice cohort of Japanese patients with a high prevalence of cardiovascular problems[J]. Clinical and experimental hypertension, 2014, 36 ( 6 ): 433-440. 被引量:1
  • 8Tausche A K, Christoph M, Forkmann M, et al. As compared to allopurinol, urate-lowering therapy with febuxostat has superioreffects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout[J]. Rheumatology international, 2014, 34 ( 1 ) : 101-109. 被引量:1
  • 9吴炜戎,郭阶明,杨薇,钟志刚,刘毅华,罗宏斌.广州市社区痛风和高尿酸血症患病现状调查[J].中华全科医学,2008,6(7):728-729. 被引量:50
  • 10Carter J D, PateUi M, Anderson S R, et al. An MRI assessment of chronic synovial-based inflammation in gout and its correlation with serum urate levels[J]. Clinical rheumatology, 2015, 34 (2) : 345- 351. 被引量:1

二级参考文献26

  • 1冯燕娴,余强.冠心病急性心肌梗死101例血尿酸值分析[J].实用全科医学,2004,2(5):403-404. 被引量:5
  • 2姜林娣.高尿酸血症与心血管疾病[J].中国临床医学,2005,12(4):751-752. 被引量:11
  • 3Becker MA, Chohan S. We can make gout management more successful now. Curr Opin Rheumatol, 2008, 20: 167-172. 被引量:1
  • 4Hamburger M, Baraf HS, Adamson TC 3rd, et al. 2011 recom- mendations for the diagnosis and management of gout and hyper- urieemia. Postgrad Med, 2011, 123(6 Suppl 1): 3-36. 被引量:1
  • 5Jordan KM, Cameron JS, Snaith M, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford), 2007, 46: 1372-1374. 被引量:1
  • 6Caspi D, Lubart E, Graft E, et al. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum, 2000, 43: 103-108. 被引量:1
  • 7Louthrenoo W, Kasitanon N, Wichainun R, et al. Effect of minidose aspirin on renal function and renal uric acid handling in healthy young adults. J Clin Rheumatot, 2002, 8: 299-304. 被引量:1
  • 8Segal R, Luhart E, Leibovitz A, et al. Early and late effects of low-dose aspirin on renal function in elderly patients. Am J Med, 2003, 115: 462-466. 被引量:1
  • 9Baker JF, Schumacher HR. Update on gout and hyperuricemia. Int J Clin Praet, 2010, 64: 371-377. 被引量:1
  • 10Huang HY, Appel LJ, Choi M J, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized Controlled trial. Arthritis Rheum, 2005, 52: 1843- 1847. 被引量:1

共引文献57

同被引文献41

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部